Citigroup Inc Treace Medical Concepts, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Citigroup Inc holds 35,422 shares of TMCI stock, worth $308,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,422

Previous 17,499 102.42%

Holding current value

$308,525

Previous $116,000 76.72%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.01 - $8.45 $89,794 - $151,449	17,923 Added 102.42%	35,422 $205,000
Q2 2024 Aug 12, 2024	BUY	$4.17 - $12.62 $41,437 - $125,404	9,937 Added 131.41%	17,499 $116,000
Q1 2024 May 10, 2024	BUY	$11.48 - $15.86 $11,824 - $16,335	1,030 Added 15.77%	7,562 $98,000
Q4 2023 Feb 09, 2024	BUY	$6.03 - $12.88 $38,718 - $82,702	6,421 Added 5784.68%	6,532 $83,000
Q3 2023 Nov 09, 2023	SELL	$12.16 - $24.87 $174,581 - $357,058	-14,357 Reduced 99.23%	111 $1,000
Q2 2023 Aug 10, 2023	BUY	$23.91 - $27.81 $335,935 - $390,730	14,050 Added 3361.24%	14,468 $370,000
Q1 2023 May 11, 2023	SELL	$20.23 - $26.22 $4,491 - $5,820	-222 Reduced 34.69%	418 $10,000
Q4 2022 Feb 09, 2023	SELL	$20.54 - $24.67 $5,627 - $6,759	-274 Reduced 29.98%	640 $14,000
Q3 2022 Nov 10, 2022	SELL	$14.71 - $24.18 $24,006 - $39,461	-1,632 Reduced 64.1%	914 $20,000
Q2 2022 Aug 10, 2022	BUY	$12.93 - $20.29 $12,374 - $19,417	957 Added 60.23%	2,546 $37,000
Q1 2022 May 12, 2022	SELL	$16.73 - $21.58 $110,819 - $142,945	-6,624 Reduced 80.65%	1,589 $30,000
Q4 2021 Feb 10, 2022	BUY	$15.48 - $26.52 $106,796 - $182,961	6,899 Added 525.04%	8,213 $153,000
Q3 2021 Nov 10, 2021	BUY	$24.15 - $30.5 $31,733 - $40,077	1,314 New	1,314 $35,000

Others Institutions Holding TMCI

# of Institutions

142

Shares Held

39.7M

Call Options Held

352K

Put Options Held

269K

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $483M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account